These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14597888)

  • 1. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events.
    Torres JL; Ridker PM
    Curr Opin Cardiol; 2003 Nov; 18(6):471-8. PubMed ID: 14597888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High sensitivity of C-reactive protein in primary prevention].
    Corrado E; Novo S
    G Ital Cardiol (Rome); 2007 Jun; 8(6):327-34. PubMed ID: 17633905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein: clinical importance.
    Bassuk SS; Rifai N; Ridker PM
    Curr Probl Cardiol; 2004 Aug; 29(8):439-93. PubMed ID: 15258556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitivity C-reactive protein in clinical practice.
    Torres JL; Ridker PM
    Am Heart Hosp J; 2003; 1(3):207-11. PubMed ID: 15785190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Ridker PM
    Circulation; 2001 Apr; 103(13):1813-8. PubMed ID: 11282915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein: a new risk assessment tool for cardiovascular disease.
    Clearfield MB
    J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis.
    Ferri C; Croce G; Cofini V; De Berardinis G; Grassi D; Casale R; Properzi G; Desideri G
    Curr Pharm Des; 2007; 13(16):1631-45. PubMed ID: 17584094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease.
    Yeh ET
    Clin Cardiol; 2005 Sep; 28(9):408-12. PubMed ID: 16250263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C-reactive protein in cardiovascular risk evaluation].
    Fabijanić D; Banić M; Kardum D
    Lijec Vjesn; 2006; 128(5-6):167-74. PubMed ID: 16910418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
    Ridker PM; Rifai N; Rose L; Buring JE; Cook NR
    N Engl J Med; 2002 Nov; 347(20):1557-65. PubMed ID: 12432042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Test in Context: High-Sensitivity C-Reactive Protein.
    Ridker PM
    J Am Coll Cardiol; 2016 Feb; 67(6):712-723. PubMed ID: 26868696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.
    Tsimikas S; Willerson JT; Ridker PM
    J Am Coll Cardiol; 2006 Apr; 47(8 Suppl):C19-31. PubMed ID: 16631506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation in atherothrombosis: how to use high-sensitivity C-reactive protein (hsCRP) in clinical practice.
    Ridker PM
    Am Heart Hosp J; 2004; 2(4 Suppl 1):4-9. PubMed ID: 15539969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and cardiovascular disease: a critical appraisal.
    Sepulveda JL; Mehta JL
    Curr Opin Cardiol; 2005 Sep; 20(5):407-16. PubMed ID: 16093760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?
    Sellmayer A; Limmert T; Hoffmann U
    Int Angiol; 2003 Mar; 22(1):15-23. PubMed ID: 12771851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
    Krintus M; Kozinski M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events.
    Huang PH; Chen JW; Lu TM; Yu-An Ding P; Lin SJ
    Clin Cardiol; 2007 Mar; 30(3):135-40. PubMed ID: 17385705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.